Advances in Cellular Technology in the Hematology Field: What Have We Learned So Far?

Despite the advances in the hematology field, blood transfusion-related iatrogenesis is still a major issue to be considered during such procedures due to blood antigenic incompatibility. This places pluripotent stem cells as a possible ally in the production of more suitable blood products. The present review article aims to provide a comprehensive summary of the state-of-the-art concerning the differentiation of both embryonic stem cells and induced pluripotent stem cells to hematopoietic cell lines. Here, we review the most recently published protocols to achieve the production of blood cells for future application in hemotherapy, cancer therapy and basic research.

References

Cho S, Webber T, Carlyle J, Nakano T, Lewis S, Zuniga-Pflucker J . Functional characterization of B lymphocytes generated in vitro from embryonic stem cells. Proc Natl Acad Sci U S A. 1999; 96(17):9797-802. PMC: 22290. DOI: 10.1073/pnas.96.17.9797. View

Larbi A, Mitjavila-Garcia M, Flamant S, Valogne Y, Clay D, Usunier B . Generation of multipotent early lymphoid progenitors from human embryonic stem cells. Stem Cells Dev. 2014; 23(24):2983-95. DOI: 10.1089/scd.2014.0171. View

Takayama N, Eto K . In vitro generation of megakaryocytes and platelets from human embryonic stem cells and induced pluripotent stem cells. Methods Mol Biol. 2011; 788:205-17. DOI: 10.1007/978-1-61779-307-3_15. View

Uzan G, Prandini M, Rosa J, Berthier R . Hematopoietic differentiation of embryonic stem cells: an in vitro model to study gene regulation during megakaryocytopoiesis. Stem Cells. 1996; 14 Suppl 1:194-9. DOI: 10.1002/stem.5530140725. View

Lu S, Li F, Vida L, Honig G . CD34+CD38- hematopoietic precursors derived from human embryonic stem cells exhibit an embryonic gene expression pattern. Blood. 2004; 103(11):4134-41. DOI: 10.1182/blood-2003-10-3575. View

Woll P, Grzywacz B, Tian X, Marcus R, Knorr D, Verneris M . Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity. Blood. 2009; 113(24):6094-101. PMC: 2699231. DOI: 10.1182/blood-2008-06-165225. View

Kovarova M, Latour A, Chason K, Tilley S, Koller B . Human embryonic stem cells: a source of mast cells for the study of allergic and inflammatory diseases. Blood. 2010; 115(18):3695-703. PMC: 2865868. DOI: 10.1182/blood-2009-08-237206. View

Kovarova M, Koller B . Differentiation of mast cells from embryonic stem cells. Curr Protoc Immunol. 2012; Chapter 22:Unit 22F.10.1-16. DOI: 10.1002/0471142735.im22f10s97. View

Choi K, Vodyanik M, Slukvin I . Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells. Nat Protoc. 2011; 6(3):296-313. PMC: 3066067. DOI: 10.1038/nprot.2010.184. View

10.

Berthier R, Prandini M, Schweitzer A, Thevenon D, Uzan G . The MS-5 murine stromal cell line and hematopoietic growth factors synergize to support the megakaryocytic differentiation of embryonic stem cells. Exp Hematol. 1997; 25(6):481-90. View

11.

Grigoriadis A, Kennedy M, Bozec A, Brunton F, Stenbeck G, Park I . Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. Blood. 2010; 115(14):2769-76. PMC: 2854424. DOI: 10.1182/blood-2009-07-234690. View

12.

Lei F, Haque R, Xiong X, Song J . Directed differentiation of induced pluripotent stem cells towards T lymphocytes. J Vis Exp. 2012; (63):e3986. PMC: 3389997. DOI: 10.3791/3986. View

13.

Kitajima K, Tanaka M, Zheng J, Sakai-Ogawa E, Nakano T . In vitro differentiation of mouse embryonic stem cells to hematopoietic cells on an OP9 stromal cell monolayer. Methods Enzymol. 2003; 365:72-83. DOI: 10.1016/s0076-6879(03)65005-6. View

14.

Panopoulos A, Belmonte J . Induced pluripotent stem cells in clinical hematology: potentials, progress, and remaining obstacles. Curr Opin Hematol. 2012; 19(4):256-60. PMC: 5558886. DOI: 10.1097/MOH.0b013e328353c78f. View

15.

Moore K, Fabunmi R, Andersson L, Freeman M . In vitro-differentiated embryonic stem cell macrophages: a model system for studying atherosclerosis-associated macrophage functions. Arterioscler Thromb Vasc Biol. 1998; 18(10):1647-54. DOI: 10.1161/01.atv.18.10.1647. View

16.

Lengerke C, Grauer M, Niebuhr N, Riedt T, Kanz L, Park I . Hematopoietic development from human induced pluripotent stem cells. Ann N Y Acad Sci. 2009; 1176:219-27. PMC: 2849804. DOI: 10.1111/j.1749-6632.2009.04606.x. View

17.

Douay L, Lapillonne H, Turhan A . Stem cells--a source of adult red blood cells for transfusion purposes: present and future. Crit Care Clin. 2009; 25(2):383-98, Table of Contents. DOI: 10.1016/j.ccc.2008.12.008. View

18.

Raya A, Rodriguez-Piza I, Guenechea G, Vassena R, Navarro S, Barrero M . Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature. 2009; 460(7251):53-9. PMC: 2720823. DOI: 10.1038/nature08129. View

19.

Yamaguchi T, Tashiro K, Tanaka S, Katayama S, Ishida W, Fukuda K . Two-step differentiation of mast cells from induced pluripotent stem cells. Stem Cells Dev. 2012; 22(5):726-34. DOI: 10.1089/scd.2012.0339. View

20.

Kennedy M, Keller G . Hematopoietic commitment of ES cells in culture. Methods Enzymol. 2003; 365:39-59. DOI: 10.1016/s0076-6879(03)65003-2. View